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Abstract
Behavioral sensitization is defined as the subsequent augmentation of the
locomotor response to a drug following repeated administrations of the drug. It is
believed to occur due to alterations in the motive circuit in the brain by stressors,
central nervous system stimulants, and similar stimuli. The motive circuit (or
mesocorticolimbic system) consists of several interconnected nuclei that determine
the behavioral response to significant biological stimuli. A final target of the
mesocorticolimbic system is the nucleus accumbens (NAc), which is a key structure
linking motivation and action. In particular, the dopaminergic innervations of the Nac
are considered to be essential in regulating motivated states of behavior such as goaldirected actions, stimulus-reward associations and reinforcement by addictive
substances. Therefore, the objective of this study was to investigate the role of
dopaminergic afferents of the NAc in the behavioral sensitization elicited by chronic
treatment with methylphenidate (MPD), a psychostimulant that is widely used to treat
attention deficit hyperactivity disorder. The dopaminergic afferents can be selectively
destroyed using catecholamine neurotoxin 6-hydroxydopamine (6-OHDA). In order
to determine whether destruction of dopaminergic afferents of the NAc prevents
sensitization, I compared locomotor activity in rats that had received infusions of 6hydroxydopamine (6-OHDA) into the NAc with that of control and sham-operated
animals. All groups of rats received six days of single daily MPD injections after
measuring their pre and post surgery locomotor baseline. Following the consecutive
MPD injections, there was a washout period of 4 days, where no injections were
given. Then, a rechallenge injection of MPD was given. Behavioral responses after

repeated MPD were compared to those after acute MPD to assess behavioral
sensitization. Expression of sensitization to MPD was not prevented by 6-OHDA
infusion into the NAc. Moreover, two distinct responses were seen to the acute
injection of MPD: one group of rats had essentially no response to acute MPD, while
the other had an augmented (‘sensitized’-like) acute response. Among rats with 6OHDA infusions, the animals with diminished acute response to MPD had intact
behavioral sensitization to repeated MPD, while the animals with increased acute
response to MPD did not exhibit further sensitization to it. This suggests that the
acute and chronic effects of MPD have distinct underlying neural circuitries.
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1. INTRODUCTION
Behavioral sensitization is the progressive increase in the motor response to a
drug following repeated exposure to it (Dafny and Yang, 2006; Pierce and Kalivas,
1997; Wolf, 1998). It is associated with increased rewarding properties of the drug
(Mead et al., 2004), and is related to mechanisms of addiction (Pierce and Kalivas,
1997; Wolf, 1998) and long term adaptations to stress (Sorg and Kalivas, 1993). It is
generally believed that behavioral sensitization occurs due to alterations in the motive
circuit or mesocorticolimbic system, which consists of dopaminergic connections
from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) (Dafny and
Yang, 2006; Ikegami and Duvauchelle, 2004; Pierce and Kalivas, 1997; Sorg and
Kalivas, 1993; Wolf, 1998). The final target of the mesocorticolimbic system, the
NAc, is considered a key structure linking motivation and action (Mogenson et al.,
1980). Particularly, the dopaminergic innervations of Nac are considered to be
essential in regulating motivated states of behavior such as goal-directed actions,
stimulus-reward associations and reinforcement by addictive substances (Meredith et.
al., 1995). The NAc appears to be involved in the expression of behavioral
sensitization (Pierce and Kalivas, 1997; Wolf, 1998). However, the role of NAc,
particularly dopamine (DA) in the NAc, in behavioral sensitization to
psychostimulants is not known. Methylphenidate (MPD) is an example of a
psychostimulant that can cause behavioral sensitization (Gaytan et al., 1996, 1997,
2000; Yang et al., 2003, 2006, 2007). MPD is a widely used treatment for attention
deficit disorder, with reports of abuse of MPD by human subjects (Kollins et al.,
2001), consistent with a potential link between neural circuits involved in addiction

and behavioral sensitization (Wolf, 1998). Thus, the role of NAc DA in behavioral
sensitization to MPD may be relevant to changes caused in the brains of those
addicted to MPD or other stimulants, the abuse of which has been reported to be
increasing (Wilens et al., 2008).

Research related to behavioral sensitization has widespread implications.
Psychostimulants cross-sensitize with each other (Brandon et al., 2001; Itzhak et al.,
2003; Achat-Mendes et. al., 2003; Rosine et al., 2009; Valvassori et al., 2007; Yang
et al., 2003), with stressors (Nikulina et al., 2004; Prasad et al., 1995), and with other
classes of drugs, such as opiates and nicotine (Celik et al., 2006; Cunningham et al.,
1997; Santos et al., 2009; Smith et al., 2009). These neural alterations are persistent
(Laruelle, 2000): prenatal stress predisposed to behavioral sensitization to stimulants
in adulthood (Henry et al., 1995). Therefore, stress, psychostimulants and other
classes of drugs seem to activate a common circuitry in the brain. However, not all
psychostimulants activate the circuitry in a similar fashion. While loss of DA
transmission in PFC eliminated behavioral sensitization to amphetamine (Bjijou et al.,
2002), Beyer and Steketee (1999) reported that a decrease in PFC DA transmission
caused a sensitized-like response to an acute injection of cocaine. Additionally,
research related to behavioral sensitization may also be relevant to psychiatric
illnesses. Similarities between neural circuitry underlying behavioral sensitization and
the dopaminergic dysfunction related to schizophrenia have been noted: both
sensitization and dopaminergic aberrations in schizophrenia have been linked to
increased transmission within subcortical dopamine systems (Laruelle, 2000). This

increased transmission has been correlated positively with manifestation of positive
psychotic symptoms like delusions, auditory hallucinations, and thought disorders.
However, Laruelle (2000) states that such a correlation is an oversimplification but,
nevertheless, concludes that schizophrenia can be termed as ‘an endogenous
sensitization process’. Thus, understanding the role of specific nuclei within the
circuitry involved in sensitization may also help understand brain alterations in
psychiatric disorders and drug addiction.

The neural circuitry underlying sensitization, sometimes referred to as the
motive circuit, comprises of several interconnected nuclei and is responsible for
appropriate behavioral responses to biologically relevant stimuli (Kalivas, 2000;
Kalivas and Duffy, 1993; Pierce and Kalivas, 1997; Wolf, 1998). The motive circuit
has been conceptualized as a gateway to decide the threshold of response and
intensity of response to environmental and pharmacological stimuli (Pierce and
Kalivas, 1997), and consists of interconnections that translate information from
limbic nuclei to motor systems (Mogenson et al., 1980). In behavioral sensitization,
the strength of these connections is altered so as to produce augmented behavioral
responses to certain stimuli (Pierce and Kalivas, 1997). The strengthening of
dopaminergic connections between VTA and NAc is believed to increase locomotor
activity in behaviorally sensitized animals (Clarke et al., 1988; Kelly and Iversen,
1976; Oades et al., 1986; Pierce and Kalivas, 1997). The alteration of DA
transmission in NAc may change the locomotor response to subsequent
pscyhostimulant administration, since the NAc is believed to screen the amount

and/or nature of information from the cortex onto lower motor circuitry (Groves,
1983). It has been suggested that drugs that modulate DA transmission within the
NAc (for example, psychostimulants) may modify locomotor activity by altering the
pattern of information that is passed onto the ventral pallidum, afferents from which
ultimately activate locomotion (Koob and Swerdlow, 1988). Thus, the sensitized
locomotor response to MPD may also be due to increased dopaminergic transmission
in the NAc, since MPD acts as indirect dopamine agonist.

Increased DA in the NAc after psychostimulant administration (Akimoto et
al., 1990; Kalivas and Duffy, 1990; Kalivas and Duffy, 1993; Pierce and Kalivas,
1995) has many effects. This increased DA in NAc has been linked to increased
locomotion (Oades et al., 1986), increase in self-administration (Roberts et al., 1980;
Maldonado et al., 1993; Wise et al., 1995) and behavioral sensitization to
psychostimulants (Pierce and Kalivas, 1997; Parson and Justice, 1993; Robinson et
al., 1988; Wolf et al., 1993). DA depletion in NAc suppresses amphetamine-induced
increase in locomotion (Kelly et al. 1975; Koob et al. 1981) and reduces selfadministration of psychostimulants (Caine and Koob, 1994); application of DA
antagonists to the NAc prevented the expression of sensitization to the
psychostimulant 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) (Ramos
et. al., 2004). It is important to note that drugs that share psychostimulant and
rewarding properties but do not cause addiction (for example, caffeine) fail to
increase DA transmission in the NAc (Acquas, et al., 2002). Thus, increased
dopaminergic transmission in NAc seems to be linked to addictive properties. Since

similar neural circuitry is involved in addiction and behavioral sensitization (Wolf,
1998), it may be deduced that increased dopaminergic transmission in the NAc may
be specifically associated with sensitization.

Behavioral sensitization has two phases: induction and expression. The
induction phase refers to the transient changes present immediately after repetitive
administration of psychostimulants that cause the increased behavioral response;
expression of behavioral sensitization is defined as the permanent and / or longlasting neural changes that maintain the augmented behavioral response to a repeat
stimulus despite cessation of continuous psychostimulant administration (Pierce and
Kalivas, 1997). In general, the NAc is considered to be involved in the expression
phase of behavioral sensitization (Kalivas and Stewart, 1991; Nestler, 1992; Pierce
and Kalivas, 1997; White et al., 1995). These phases of behavioral sensitization are
apparently due to changes at different cerebral loci: while the transient changes are
believed to be located at the ventral tegmental area (VTA), the NAc is linked to the
long-lasting neural changes associated with repeated psychostimulant administration
of cocaine and amphetamine (Pierce and Kalivas, 1997; Wolf, 1998). As MPD is
pharmacologically similar to amphetamine and cocaine, it can be conjectured that the
NAc is involved in the expression of sensitization to MPD.

However, NAc is a functionally heterogeneous brain region consisting of a
dorsolateral core and a ventro-medial shell (DiChiara, 2002; DiChiara et. al., 2004;
Fuchs et. al., 2008). The roles of the core and the shell of NAc, reported in literature,

differ. For example, it has been reported that while the core is believed to be involved
in motor functions, the shell is believed to be more involved in emotion (Alheid et al.,
1988, Heimer et al., 1991). Others have also reported the role of the shell in
Pavlovian learning and the use of short-term memory in goal-directed behavior, while
the expression of motivation is linked to DA transmission in the core (DiChiara,
2002). With regards to psychostimulant administration, the NAc core and shell also
differ in the changes in DA transmission. Some report that the effect of
psychostimulants on the spatial distribution in NAc is dependent on the dose of the
psychostimulant. For example, amphetamine causes a preferential increase in DA
transmission in the shell at lower doses, but similar increases across the shell and core
at higher doses (DiChiara, 2002). Similar trends were observed for subcutaneous
injections of morphine, amphetamine and intraperitoneal injections of cocaine
(DiChiara, 2002). There are also contradictory reports about the changes in the
nucleus accumbens core and shell associated with psychostimulant sensitization.
Some report that the increase in DA transmission in sensitized animals occur in the
NAc core (Cadoni et al., 2000), while the NAc shell is involved in the initial action of
the same drugs (DiChiara, 2002). Yet, others report that increase in DA transmission
occurs in the NAc shell is associated with behavioral sensitization (Pierce and
Kalivas, 1995). The above mentioned results indicate that the role of sub-regions of
NAc in psychostimulant sensitization is unclear.

The NAc shell and core are connected with the prefrontal cortex (PFC), also
involved in behavioral sensitization to MPD (Wanchoo et al., 2009, 2010). Both

glutamate cells of the PFC (Wanchoo et. al., 2009) and dopaminergic afferents of the
PFC (Wanchoo et al., 2010) were essential for behavioral sensitization to MPD. Also,
activation of glutamatergic afferents from the PFC to the nucleus accumbens core is
believed to be essential for reinstatement of drug-seeking behavior of
psychostimulants (McFarland et al., 2003) while the dopaminergic afferents of PFC
are believed to modulate DA levels in NAc core as well as shell in response to
psychostimulants and stress (King et. al., 1997). Moreover, reciprocal connections
exist between the shell and core of NAc (van Dongen et al, 2005) such that one takes
up the functions of the other following selective destruction of either (Schoenfeld and
Hamilton, 1977). Thus, this study did not specifically aim to differentiate between the
subregions of NAc with respect to their role in sensitization to MPD.

The NAc has been reported to be structurally altered by repeated
administration of MPD: chronic exposure of MPD has been shown to increase the
density of dendritic spines on DA receptors in NAc and increase the expression of
∆FosB (Kim et. al., 2009), the transcription of which is linked to addictive properties
of psychostimulants (Nestler, 2008). In a previous study (Podet et al., submitted for
publication) electrolytic lesion of the nucleus accumbens eliminated the expression of
behavioral sensitization to MPD, and caused a significantly greater increase in
locomotor activity upon the acute injection as compared to the increase following
acute injection in the control group. Since electrolytic lesions are non-specific, it is
possible that the results reported by Podet et al (submitted for publication) may be
due to destruction of dopaminergic afferents of NAc. The dopaminergic afferents to

the NAc can be destroyed by administering 6-hydroxydopamine (6-OHDA). 6OHDA is a selective neurotoxin that selectively eliminates catecholaminergic
pathways. Therefore, the hypothesis of the current study was that 6-OHDA lesions of
the NAc would reduce baseline locomotor activity, and prevent behavioral
sensitization to MPD, without eliminating the acute response to MPD. A standard
sensitization protocol was used and locomotor activity was recorded with an
automated infrared beam-crossing system.

2. MATERIALS AND METHODS
2.1. Animals
Thirty-seven male Sprague Dawley rats were purchased from Harlan,
Madison, Wisconsin, USA. The animals were housed two per cage in a
temperature and humidity controlled animal room for at least 3 -5 days before the
start of the experiment to acclimatize them. The temperature and humidity of the
room were maintained at 71 ± 2ºF and 57 ± 5%. The animals were kept on 12:12
light / dark cycle with the lights on at 06:00 to maintain a stable circadian rhythm,
since behavioral sensitization to MPD is time-dependent (Gaytan et al., 2000).
The animals had access to food and water throughout the day, except for the time
spent in recording chambers (2 hrs). The animals weighed at least 180 g (range
180 – 220 g), i.e., they had reached adulthood at the commencement of the
experiment. Adult male Sprague Dawley rats were used since female rats have
reproductive cyclicity, which might affect the results of the experiment: for
example, estrogen, the levels of which fluctuate throughout the menstrual cycle,
augments the acute behavioral and neurochemical responses to psychostimulants
(Dafny and Yang, 2006; Kelly et al., 1999; Van Haaren and Meyer, 1991). Upon
completion of the experiment, the rats were anesthetized with pentobarbital and
perfused intracardially with 10% formaldehyde, and their brains were stored in
10% formaldehyde for at least 48 hours for fixation.

2.2. Experimental protocol
The animals were acclimatized to the recording chamber for 15 – 20
minutes before each injection and / or recording session. On experimental day (ED) 1,
animals were injected with 0.8ml of 0.9% saline after 15 minutes of acclimatization
to the recording chamber (Table 1), and the locomotor activity baseline was recorded
for two hours post injection in an open field assay using Accuscan Analyzer.
Locomotor activity was recorded for two hours post injection since the effect of MPD
lasts about 50 – 80 minutes depending upon the dose of MPD (Gaytan et al., 1997;
Yang et al., 2003, 2007). On ED 2, the animals were divided into the following
groups – control, sham-operated, and 6-hydroxydopamine lesion in NAc group. Two
sham groups were used – one group in which saline was injected in NAc (surgical
shams) while the other group consisted of animals that underwent anesthesia and skin
incision without drilling holes in the skull (non-surgical shams). Animals with higher
locomotor baseline (> 5000 cm HA) were chosen for the NAc lesion group since 6OHDA lesions of NAc have been reported to cause a decrease in locomotor activity
(Oades et al., 1986; Austin and Kalivas, 1991; AndЀn and Jackson, 1975; Costall et
al., 1976; Cools, 1977; Makanjoula and Ashcroft, 1982; Selling and Clarke, 2003,
2006). Similarly, animals in the surgical sham group had a higher locomotor baseline
comparable to the baseline of the lesion group. The higher locomotor baseline was
chosen for the surgical shams to determine whether administering saline in NAc
caused changes in locomotor activity. Sham and lesion surgeries were performed on
ED 2, with a recuperation period of five days from ED 3 through ED 7. The postsurgery baseline locomotor activity was recorded on ED 8 following saline injection

to determine whether surgery changed the baseline locomotor activity. All groups
were then administered a single dose of 2.5 mg/kg MPD daily at around 06:45 am for
six days (ED’s 9 through 14) (Table 1) and their locomotor activity was recorded.
After six days of MPD administration, there was a washout period of four days (ED
15 to 18), where no injections were given. Finally, a rechallenge injection of 2.5
mg/kg MPD was administered to all three groups on ED 19 (Table 1) and locomotor
activity was recorded.

Table 1: Experimental protocol
Group

Day 1

Day 2

Control

Saline

NonSurgical
shams
Surgical
shams

Saline

Surgery

Saline

Lesion

Saline

Surgery –
saline in
NAc
Surgery –
6-OHDA
in NAc

Days 3-7

Day 8

Days 9 –
14
2.5mg/kg
MPD
2.5mg/kg
MPD

Days
Day 19
15-18
Washout 2.5mg/kg
MPD
Washout 2.5mg/kg
MPD

No
treatment
No
treatment

Saline

No
treatment

Saline

2.5mg/kg
MPD

Washout 2.5mg/kg
MPD

No
treatment

Saline

2.5mg/kg
MPD

Washout 2.5mg/kg
MPD

Saline

2.2. 1. Surgeries
Sham surgeries: On ED 2, rats in the two sham groups, surgical shams and nonsurgical shams, were anaesthetized with 40 mg/ kg pentobarbital. When the rat was
under anesthesia, an incision was made on the skull to expose the bregma. For
surgical shams, holes were drilled in the skull 1.7 mm anterior from the bregma and
1.6 mm lateral to the midline. The position of the co-ordinates was based on Paxinos
and Watson (1986). Then, a 27 G needle was inserted to a depth of 6.8 mm, and 2.5
µl of saline was injected over 25 s. After saline was injected, the needle was kept in
place for additional six minutes to allow the liquid at the tip of the needle to diffuse
(Jaskiw et. al., 1990; Li and Wolf, 1997; Li. et. al., 1999). The procedure was
repeated on the other side. The skin was stapled back together, and the rats were
allowed to recuperate for five days (ED 3 through ED 7). For the nonsurgical sham
group, a similar procedure was carried out under anesthesia, except that holes were
not drilled in the skull. The purpose of two sham groups was to determine whether
injecting liquid in NAc caused volume damage or altered motor activity.
Bilateral 6-OHDA administration to NAc: Since desipramine, a noradrenergic
blocker, may cause its own effects (Ainsworth et al., 1998), desipramine, was not
given. Noradrenergic blockers are generally given to ensure that 6-OHDA destroys
only the dopaminergic afferents (Beyer and Steketee, 1999; Bjijou et al., 2002). 40
mg/ kg of pentobarbital was administered. Once the animal was under anesthesia, the
bregma was exposed by making an incision and two holes were drilled above the
NAc at 1.7 mm anterior from the bregma and 1.6 mm lateral from the midline. A 27G
needle was inserted into the holes and lowered to depths of 6.8 mm (Paxinos and
Watson, 1986) and 2.5 µl of 6-OHDA solution (Taylor and Robins, 1986) was

injected. The 6-OHDA solution constituted of 3 mg 6-OHDA and 2 mg of ascorbic
acid per 1 ml of 0.9% isotonic saline. 3% ascorbic acid was added to prevent the rapid
oxidation of 6-OHDA (Wanchoo et. al., 2010). The needle was left in position for six
minutes to allow diffusion of the drug. 6-OHDA solution was injected on the other
side similarly, and the wound closed with staples. The animals rested for five days
(ED 3 through ED 7).

2.2. 2. Drugs
A dose of 2.5 mg/kg MPD was selected because previous work showed that this dose
was optimal for eliciting behavioral sensitization (Gaytan et al., 1997, 2000; Yang et
al., 2003, 2006, 2007). 2.5 mg / ml of MPD was prepared by dissolving
methylphenidate hydrochloride in 0.9% isotonic saline. For injections, the animals
were weighed and 2.5 mg / kg of MPD was administered. Saline was added to all
injection such that the volume of all injections was 0.8 cc. The drug (on ED 9 through
14, and ED 19) or saline (on ED 1 and ED 8) was administered intraperitoneally at
around 06:45 am. The time of administration of the drug was chosen because MPD
elicits optimal behavioral sensitization when given at the beginning of the light cycle
(Gaytan et al., 2000).

2.2.3. Locomotor recordings
Locomotor activity was recorded using computerized animal activity monitoring
(CAAM; Accuscan Instrument, Inc., Columbus, OH) in open field cages (40.5
cm×40.5 cm×31.5 cm). The monitoring device consisted of two levels of infrared
beams of frequency 100 Hz at 6 cm and 12.5 cm from the base of the cage. There was

one animal per cage. Beam crossings, representing motor activity, were counted in
ten-minute units by Accuscan Analyzer and downloaded into OASIS. Further
analysis of beam interruptions was done in OASIS by sorting and quantifying the data
into different locomotor indices. If two or more consecutive beams were interrupted
at least 1 s apart, then the activity monitoring system interpreted it as a motor
movement. If the same beam was interrupted, it was interpreted as stereotypic
activity. If there was difference of > 1 s between the interruptions of the same beam,
it was counted as a different episode of stereotypic movement (Gaytan et al., 1996).
Horizontal activity (HA) was defined as the overall locomotor activity. Total distance
(TD) was the sum of the total forward ambulation in centimeters, and number of
stereotypic movements (NOS) provided the measure of the total number of repetitive
episodes (Askenasy et al., 2007; Gaytan et al., 1996, 1997, 2000; Yang et al., 2003,
2006, 2007).

2.3. Histology
The animals were anaesthetized with sodium pentobarbital and perfused intracardially
with 10% formaldehyde. The brains were extracted and kept in 10% formaldehyde
for at least 48 hours for fixation. The brains were then sliced into 40 µm sections
using a Microm HM 505E cryostat (Microm GmbH, Germany). The slides were dried
for at least 24 hours, and stained with Cresyl Violet (Riickert et. al., 1997) between
24 to 72 hours after being sliced. The purpose of the staining was to assess the
accuracy of lesions.

2.4. Data Analysis
Locomotor activity was recorded by the CAAM and Accuscan Analyzer as 10
minute activity units for different indices. The sum of the total activity in 2 hours
was calculated for HA, TD and NOS (Askenasy et. al., 2007; Gaytan et. al., 1996,
1997, 2000; Yang et. al., 2003, 2006, 2007). The locomotor activity for each
group of animals was compared across days to note the effects of treatment. The
difference in locomotor activity between days in the lesion group was compared
to the differences in locomotor activity between corresponding days in the control
group. Statistical analyses used motor activity as dependent variable and day and
group as independent variables. To analyze the effect of surgery on locomotor
activity, locomotor activity on ED 8 (post-surgery baseline) was compared to presurgery baseline (ED 1). Similarly, activity following acute administration of
MPD (ED 9) was compared to post-surgery baseline (ED 8) to observe the acute
effect of MPD. Acute injection of MPD caused a biphasic response in the lesion
group. Based upon their response to the acute injection of MPD, animals in the
lesion group were divided into two groups: 1) high acute responders, who had
significantly greater locomotor activity upon the acute injection of MPD or 2)
acute non-responders, who exhibited little or no change in baseline locomotor
activity after the 1st injection of MPD. Data was analyzed for both all the animals
in the lesion group combined, and for the two response groups separated: high
acute responders and acute non-responders. Activity following the 6th consecutive
injection of MPD (ED 14) was compared to post-surgery baseline (ED 8) and
acute administration of MPD (ED 9) to determine the effects of repetitive

administration of MPD. Finally, activity following the rechallenge MPD injection
(ED 19) was compared to that after acute administration of MPD (ED 9) to
determine the expression of sensitization. Analysis of variance (ANOVA) with
post hoc analysis using the Fisher Least Significant Difference (LSD) test if
ANOVA was significant (Yang et. al., 2003, 2007) was used, and differences
were considered statistically significance if two-tailed p ≤ 0.05.
Alternatively, the locomotor response of the two lesion groups (high acute
responders and acute non-responders) was compared to the locomotor response
observed in the control group for different days since both groups had similar
post-surgery baselines.

3. RESULTS:
Effects of administration of 6-OHDA in the NAc were evaluated by comparing
locomotor activity of the 6-OHDA lesioned group in the following locomotor indices:
horizontal activity (HA), total distance (TD) and number of stereotypic movements
(NOS). The histograms in the figures are group means of the total activity recorded
two hours post injection. The error bars show standard errors. The figures labeled ‘A’
display data for all the groups – control, nonsurgical sham, surgical shams, and lesion
groups (all lesion animals grouped together). The figures labeled ‘B’ indicate the
activity of the two lesion group responses separated and compared to the control
group. ANOVA was used to compare significance of differences and significance
was set at p ≤ 0.05.

Effect of 6-OHDA administration in NAc on locomotor baseline:
To observe the effect of time (control group) and surgery (surgical shams,
non-surgical shams and lesion group) on the locomotor activity, pre- and post-surgery
baseline locomotor activity of all groups was compared (Fig. 1). Activities did not
differ for control animals in HA (F (1, 7) = 0.009, p = 0.925), TD (F (1, 7) = 0.001, p
= 0.97) and NOS (F (1, 7) = 0.012, p = 0.91). Similarly, neither the nonsurgical sham
group HA (F (1, 7) = 0.009, p = 0.93), TD (F (1, 7) = 0.12, p = 0.73) and NOS (F (1,
7) = 0.18, p = 0.69) nor surgical shams HA (F (1, 3) = 0.80, p = 0.40), TD (F (1, 3) =
0.35, p = 0.57) or NOS (F (1, 3) = 1.74, p = 0.23) had significantly different baseline
activities after surgery in any of the three indices. This is in agreement with previous
reports that motor indices are stable over time (Bjork et al., 1998; Gaytan et al.,

1998). However, the 6-OHDA in NAc lesion group had significantly decreased
locomotor activity after surgery: HA (F (1, 16) = 8.52, p = 0.006), TD (F (1, 16) =
9.05, p = 0.005) or NOS (F (1, 16) = 7.74, p = 0.009) on ED 8 compared to ED 1.
Thus, reduced locomotor activity was seen in the lesion group, while the control and
both the sham groups did not differ in their baseline locomotor activity.

FIGURE LEGEND: Figure 1 compares the pre-and post surgery baseline of all the
groups. It was seen that the locomotor baseline of rats did not change much with time
in horizontal activity (HA; 1st graph), total distance (TD; 2nd graph) and number of
stereotypy (NOS; 3rd graph). Similarly, surgery in itself did not cause significant
change in locomotor baseline (non-surgical and surgical shams) in all three indices.
However, 6-OHDA administration in NAc caused a significant reduction in
locomotor baseline (lesion group) in all three indices. ∆ indicates significance
difference (p ≤ 0.05) as compared to pre-surgery baseline.
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Effect of acute MPD administration: To observe the effect of acute injection of
MPD, locomotor activity on ED 9 (after MPD injection) was compared to ED 8 (postsurgery baseline). Acute injection of MPD caused a significant increase in locomotor
activity in the control group (Fig 2A) in HA (F (1,7) = 16.28, p = 0.001), TD (F (1,7)
= 7.16, p = 0.02) or NOS (F (1,7) = 17.56, p = 9 * 10^- 4) and in the non-surgical
sham group: HA (F (1, 7) = 4.43, p = 0.05), TD (F (1, 7) = 4.50, p = 0.05) and NOS
(F (1, 7) = 4.20, p = 0.05) (Fig. 2A). The surgical shams, however, did not have
significantly increased locomotor activity following the 1st injection of MPD: HA (F
(1, 3) = 1.37, p = 0.28), TD (F (1, 3) = 1.45, p = 0.27) and NOS (F (1, 3) = 1.21, p =
0.31). The lesion group, as a whole, did not have significantly different activity upon
the acute injection of MPD either: HA (F (1, 16) = 2.21, p = 0.14), TD (F (1, 16) =
2.22, p = 0.14) and NOS (F (1, 16) = 3.07, p = 0.08) (Fig. 2A).

FIGURE LEGEND:

Figure 2A shows the acute response to MPD in control,

surgical and non-surgical sham groups. Acute injection of MPD caused a significant
increase in all three indices of locomotor activity for control and surgical sham
groups. The non-surgical shams showed an increase in locomotor activity, but it did
not reach significance probably due to small sample size. The lesion group did not
show a significant increase in activity. ∆ indicates significance difference (p ≤ 0.05)
as compared to post-surgery baseline.

Figure 2A

HA: Acute effect of MPD
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However, among rats with 6-OHDA NAc lesions, there appeared to be two
distinct responses to acute MPD administration (Fig. 2B-1 and 2B-2): some animals
had significantly increased locomotor activity upon MPD administration, while others
had no effect of acute MPD.

FIGURE LEGEND:

Figures 2B-1 and 2B-2 show that some animals in the

lesion group responded positively to the psychostimulant (MPD) injection, and others
did not exhibit a change in locomotor baseline upon psychostimulant administration.
Figure 2B-2 shows the change in locomotor activity of each individual rat in the
lesion group after the 1st injection of MPD.

Figure 2B-1
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The distinctiveness of the responses persisted throughout the rest of the
experiment. Therefore, the animals in the lesion group were divided into two groups –
acute non-responders (N= 10), which did not exhibit increased locomotor activity
after acute psychostimulant administration (Fig. 2B-2, Fig. 2C), and high acute
responders (N= 7), with significantly increased locomotor activity after acute
administration of MPD (Fig 2B-2, Fig 2C). Fig 2C compares the activity of the
control group to the two lesion groups. In the acute non-responders, acute injection of
MPD did not cause any change in locomotor activity in HA (F (1, 9) = 1.91, p =
0.18), TD (F (1, 9) = 0.55, p = 0.46) and NOS (F (1, 9) = 0.92, p = 0.35), while acute
injection of MPD caused a significant increase in locomotor activity in high acute
responders: HA (F (1, 6) = 8.98, p = 0.01), TD (F (1, 6) = 5.37, p = 0.04) or NOS (F
(1, 6) = 21.31, p = 5 * 10^ -4). Thus, acute administration of MPD caused a
significant increase in locomotor activity in the control and non-surgical sham groups.
Two responses (augmented locomotor activity and baseline locomotor activity) were
seen in the lesion group following acute injection of MPD.

FIGURE LEGEND:

Figure 2C indicates the acute response to MPD

injection of the lesion group, separated out: i.e., compares the response of 1st MPD
injection of acute non-responders (the lesion animals that did not have a positive
change of locomotor activity in figure 2B-2) and high acute responders (lesion
animals with positive change in locomotor activity in figure 2B-2) to the control
group.

Figure 2C
HA: Acute effect of MPD
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In order to check whether differences in baseline locomotor activity may have
contributed to divergent responses to acute injection of MPD, the post surgery
baselines of the two groups were compared (Fig. 2D) and no significant differences
were found between the groups [HA (F (2, 16) = 0.85, p = 0.37)]. Thus, the two
responses seen in the lesion group after acute MPD injection were not due to
differences in locomotor baseline.

FIGURE LEGEND:

Since acute response to psychostimulant may differ

based on locomotor baseline, figure 2D compares the post-surgery baseline of the
acute non-responders and high acute responders. The baselines did not differ
significantly and thus differences in baseline locomotor activity did not contribute to
the difference in response to acute injection of MPD amongst lesioned animals. ∆
indicates significance difference (p ≤ 0.05) as compared to post-surgery baseline.

Figure 2D
HA: Comparing post surgery baseline of high acute
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Effect of 6th consecutive injection of MPD:
The increase in locomotor activity after the acute administration of MPD was
maintained following the 6th consecutive daily injection of MPD in the control group
in [ED 8 compared to ED 14: HA (F (1, 7) = 29.13, p = 9.4 *10^-5), TD (F (1, 7) =
9.46, p = 0.008) or NOS (F (1, 7) = 30.16, p = 7.93 * 10^ -5)] (Fig. 3A). However, the
locomotor activity after 6th injection of MPD was not significantly different from the
acute effect of MPD for the control group: HA (F (1, 7) = 3.07, p = 0.10), TD (F (1,
7) = 0.61, p = 0.45) and NOS (F (1, 7) = 1.98, p = 0.18). Similar results were seen in
the non-surgical sham group, i.e., the increase in locomotor activity was maintained
after the 6th injection of MPD [ED 8 compared to ED 14: HA (F (1, 7) = 5.70, p =
0.03), TD (F (1, 7) = 4.62, p = 0.04) and NOS (F (1, 7) = 4.94, p = 0.04)]. However,
like controls, the activity on ED 14 was not significantly different from that on ED 9
for non-surgical shams in HA (F (1, 7) = 0.32, p =0.58), TD (F (1, 7) = 1.03, p =
0.33) and NOS (F (1, 7) = 3 * 10^ -4, p = 0.98)]. Contrary to controls and nonsurgical shams, the surgical shams had a significantly greater increase in locomotor
activity on the 6th consecutive day on MPD injection than on ED 8 [HA (F (1, 3) =
36.94, p = 9 * 10^ -4), TD (F (1, 3) = 11.28, p = 0.01) and NOS (F (1, 3) = 51.72, p =
3.6* 10^ -4)] and ED 9 [HA (F (1, 3) = 20.31, p = 0.004), TD (F (1, 3) = 9.05, p =
0.02) and NOS (F (1, 3) = 6.35, p = 0.04)]. The lesion group, as a whole, had
significantly greater activity on the 6th day of MPD injections as compared to postsurgery baseline [HA (F (1, 16) = 13.73, p = 7 * 10^-4), TD (F (1, 16) = 9.67, p =
0.0039) and NOS (F (1, 16) = 25.81, p = 1.57* 10^-5)] but not significantly different

compared to the 1st injection of MPD (ED 9): [HA (F (1, 16) = 2.21, p = 0.15), TD (F
(1, 16) = 2.23, p = 0.15) and NOS (F (1, 16) = 3.07, p = 0.089)] (Fig. 3A)

FIGURE LEGEND:

Figure 3A compares the locomotor response to the 6th

injection of MPD (ED 14, MPD 6) to the locomotor response after 1st injection of
MPD (ED 9, MPD 1) and post-surgery – baseline (ED 8). In the control and surgical
shams, similar levels of increased activity were seen after the acute and 6th
consecutive daily injection of MPD, as compared to the post-surgery baseline. The
surgical shams had significantly elevated activity compared to both the acute
injection of MPD and the post-surgery baseline. In the lesion group (n = 17),
locomotor activity after 6th injection was significantly elevated as compared to the
post-surgery baseline. ∆ and <> indicate significantly different (p ≤ 0.05) as
compared to post-surgery baseline and acute injection of MPD respectively.

Figure 3A
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With the lesion group divided into two based upon their response to the acute
injection of MPD, the high acute-responders exhibited a significantly greater increase
in locomotor activity following the 6th consecutive daily injection of MPD compared
to their post-surgery baseline in HA (F (1, 9) = 4.41, p = 0.05), and NOS (F (1, 9) =
10.53, p = 0.004), even though they did not have increased activity after the acute
MPD injection (Fig. 3B). However, TD did not show a significant increase in
locomotor activity even after the 6th injection (F (1, 9) = 2.71, p = 0.11). The increase
in locomotor activity seen after the 6th injection in acute non-responders was
significant compared to activity on ED 9 in all three indices: HA (F (1, 9) = 8.36, p =
0.009), TD (F (1, 9) = 4.31, p = 0.05) and NOS (F (1, 9) =17.41, p = 5 * 10^-4). The
high acute responders maintained similar increases in locomotor activity to that on
ED 9, after the first injection of MPD [ED 14 compared to ED 8: HA (F (1, 6) =
10.52, p = 0.007), TD (F (1, 6) = 8.01, p = 0.01) or NOS (F (1, 6) = 15.34, p = 0.02)]
(Fig. 3B). This increase was not significant compared to activity on ED 9: HA (F (1,
6) = 0.001, p = 0.98), TD (F (1, 6) = 0.13, p = 0.73) and NOS (F (1, 6) = 0.15, p =
0.70).

FIGURE LENGED:

Figure 3B compares the MPD response after 6th

injection to the acute response and post-surgery baseline for control group, and acute
non-responders and high acute responders (lesion group separated, based on their
acute response). Locomotor activity after the 6th injection was equally augmented in
all three groups, irrespective of their initial response to MPD. ∆ indicates
significantly different (p ≤ 0.05) as compared to post-surgery baseline, while <>
indicates significantly increased activity as compared to the 1st injection of MPD.

Figure 3B
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Thus, locomotor activity after the 6th injection of MPD was maintained but not
significantly elevated in the controls and non-surgical shams. The surgical shams had
significantly greater locomotor activity, even compared to the acute injection of
MPD. In the acute non-responders, locomotor activity was significantly elevated
compared to the response to the acute injection, while the high acute responders had
similar levels of locomotor activity on both the 1st and 6th injection of MPD.

Effect of MPD rechallenge injection:
On rechallenge with 2.5 mg/kg MPD after four days of washout, a sensitized
response i.e., a significantly greater increase in locomotor activity than that after the
initial injection of MPD, was seen in the control group (Fig. 4A) in HA (F (1, 7) =
9.37, p = 0.008), and TD (F (1, 7) = 11.31, p = 0.004), but not NOS (F (1, 7) = 0.20, p
= 0.66). A similar sensitized response was seen in the nonsurgical sham group for HA
(F (1, 7) = 4.84, p = 0.04), and TD (F = 4.25, p = 0.05), but not NOS (F = 0.35, p =
0.55). However, the surgical shams did not exhibit a sensitized response for any of
the three indices: HA (F (1, 3) = 2.88, p = 0.14), TD (F (1, 3) = 3.53, p = 0.11) and
NOS (F (1, 3) = 0.91, p = 0.38). The lesion group, as a whole, did not show a
sensitized response, i.e., locomotor on ED 19 (rechallenge injection) was not
significantly different than the locomotor activity seen on ED 9 (1st injection) (Fig.
4A): HA (F (1, 16) = 1.30, p = 0.26), TD (F (1, 16) = 0.49, p = 0.48) and NOS (F (1,
16) = 1.76, p = 0.19).

FIGURE LEGEND:

Figure 4A compares the activity after the MPD

rechallenge injection, administered after the 6 consecutive injections and four days of
washout, to the locomotor activity after the 1st injection. Control and surgical shams
displayed a sensitized response, i.e., significantly elevated locomotor activity as
compared to the activity after the 1st injection. Non-surgical shams had increased
locomotor activity, but the increase was not significant. The lesion group (n = 17) did
not show a sensitized response.

Figure 4A
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The lesion group, divided by their acute response to MPD, exhibited other
patterns. The acute non-responders (Fig. 4B) had an augmented locomotor response
upon rechallenge compared to the acute injection, for HA (F (1, 9) = 7.60, p = 0.01)
and NOS (F (1, 9) = 17.42 p = 5 *10 ^-4) but not TD (F (1, 9) = 3.12, p = 0.09), while
in the high acute responders, the locomotor response to the rechallenge injection was
not significantly different from that to the acute injection [HA (F (1, 6) = 0.06, p =
0.81), TD (F (1, 6) = 7* 10^-4, p = 0.98) and NOS (F (1, 6) = 0.66, p = 0.43)]. Thus,
a significantly increased locomotor response was seen upon the rechallenge injection
in the control, non-surgical sham and acute non-responders (lesion) groups. The high
acute responders exhibited similar levels of locomotor activity to both the first and
rechallenge injection of MPD.

FIGURE LEGEND:

Figure 4B compares the locomotor response to the

rechallenge injection to the locomotor response to the 1st injection of MPD. The
control group expressed sensitization, i.e., had significantly elevated activity. The
acute non-responders had significantly elevated activity, comparable to the sensitized
response of the control group, even though the 1st injection of MPD had not elicited a
significant increase in activity. The high acute responders had similar levels of
activity on the acute as well as rechallenge injection; both of which were of similar
magnitude to the sensitized response in the control group. Thus, this suggests that
neural circuitry underlying acute response to MPD is different than that underlying
the expression of behavioral sensitization.

Figure 4B
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Similar response to rechallenge injection in both lesion groups:
Since both the lesion groups had similar baseline activity to the control group,
the locomotor response to the MPD rechallenge injection in the control and the lesion
groups was compared using one-way ANOVA with group as the variable .There were
no significant differences in response to the rechallenge injection between control and
acute non-responders for HA (F (2, 17) = 0.87, p = 0.36) and NOS (F (2, 17) = 0.007,
p = 0.93)] and between the control and the high acute responders [HA (F (2, 14) =
0.14, p = 0.71), TD (F (2, 14) = 0.003, p = 0.95) and NOS (F (2, 14) = 0.13, p =
0.72)]. TD travelled after the rechallenge injection was significantly greater in the
control group as compared to the acute non-responders (F (2, 17) = 8.23, p = 0.01).
Thus, similar levels of activity were seen in the control and both the lesion groups
upon the rechallenge injection.

‘Sensitized-like’ augmented response to acute injection in high acute responders:
No significant difference was found between the acute and rechallenge
injection in acute high responders [HA (F (1, 6) = 0.06, p = 0.81), TD (F (1, 6) = 7*
10^-4, p = 0.98) and NOS (F (1, 6) = 0.66, p = 0.43)]. Moreover, the change in
locomotor activity in the acute non-responders was significantly greater than that in
the control group in HA (F (2, 14) = 5.36, p = 0.04), but not in TD (F (2, 14) = 3.01, p
= 0.11) and NOS (F (2, 14) = 2.13, p = 0.16). Thus, significantly greater increase in
locomotor activity, relative to the increase in the control group, was observed upon
acute injection of MPD in the high responders group i.e., a ‘sensitized-like’ response
was seen to the acute injection of MPD itself.

4. DISCUSSION:
The aim of the study was to determine whether 6-OHDA lesions of NAc
eliminated the expression of behavioral sensitization to MPD. The first specific aim
was to verify whether 6-OHDA lesions reduced baseline locomotor activity and it
was confirmed that eliminating the dopaminergic afferents to the NAc reduced the
locomotor activity of the lesion group. The second specific aim was to determine
whether the expression of behavioral sensitization was eliminated in the lesion group,
but a sensitized response was seen in the lesioned group that had low acute response
to MPD. Therefore, injection of 6-OHDA into the NAc did not prevent the expression
of sensitization, as hypothesized. However, other results were found. Notably, half
the animals in the lesion group had significantly increased locomotor activity (high
acute responders) after acute injection of MPD, while the other half exhibited no
significant change from baseline locomotor response (low acute responders) to the
acute injection of MPD. One possible explanation for this, discussed below, is that
only part of the NAc is involved in the acute response to MPD. Moreover, even
though the animals in the lesion group varied in the acute response to MPD, all the
animals in the lesion group had an increased response by the time of the final
injection, suggesting that the neural circuitry underlying acute effect of MPD is
different from the neural circuitry underlying long-term changes caused by MPD.
Lastly, it was noted that the animals that exhibited increased locomotor response
(high acute responders) had an increased response to the acute injection of MPD.
The different groups of animals, control, surgical, non-surgical and lesion
animals had differing baselines. It has been reported that animals with differences in

individual baseline locomotor activity have different susceptibility to sensitization to
psychostimulants (Hooks et al., 1991). These authors found that the rats with higher
locomotor activity had a greater locomotor response to acute injection of
amphetamine and that a direct correlation existed between response to novelty and
magnitude of locomotor sensitization. Results similar to Hooks et al. (1991) were
reported by Demimere et al., (1989) and Piazza et al., (1989). In our experiment, the
non-surgical shams and lesion animals had higher locomotor baselines (pre-surgery
baselines), though locomotor activity after 6-OHDA administration (post-surgery
baseline) of the lesion group was expected to decline. Thus, according to the results
of Hooks et al (1991), a greater locomotor response to acute injection and augmented
magnitude of locomotor sensitization was expected from animals with higher baseline
activity. Since previous reports from the laboratory had shown sensitization in
animals with the lower locomotor baselines (seen in control and surgical sham group
here), we did not expect differences in locomotor baseline to cause any change in
acute or chronic effect of MPD.
Locomotor activity in rats has been reported to be stable over time (Bjork et
al., 1998; Gaytan et al., 1998). Thus, changes in locomotor activity can be attributed
to the treatment given. Additionally, it has been demonstrated that handling and
injecting saline in rats does not affect locomotor activity for more than 5 minutes, and
repeated injections of saline do not have any effect on locomotion (Yang et al., 2007).
Similar to these reports, it was observed that locomotor activity on experimental day
1 following saline injection (pre-surgery baseline) was similar to the locomotor
activity on experimental day 8 following saline injection (post-surgery baseline) in

control and both the sham groups. In contrast, in the 6-OHDA in NAc lesion group,
there was a decrease in baseline activity. While most studies report that DA in the
NAc is correlated with increased locomotor activity, consistent with reduction in
motor activity after 6-OHDA lesions of the NAc (Pijnenburg and VanRossum, 1973;
Oades et al., 1986; Austin and Kalivas, 1991; Anden and Jackson, 1975; Costall et al.,
1976; Cools, 1977; Makanjoula and Ashcroft, 1982; Selling and Clarke, 2003, 2006),
Kelly and Iversen (1976) reported hyperactivity in 6-OHDA NAc lesioned rats
compared to the control rats, while Weissenborn and Winn (1992) reported no
changes in spontaneous locomotor activity following 6-OHDA lesions of the NAc.
The hyperactivity reported by Kelly and Iversen (1976) has been called ‘paradoxical;’
and they rationalized that this hyperactivity may represent the failure of the lesioned
rats to habituate to the novel environment. Our results agree with reports (Makanjoula
and Ashcroft, 1982; Selling and Clarke, 2003, 2006) of a decrease in spontaneous
activity following 6-OHDA lesions of the NAc. Since the decrease in locomotor
activity following 6-OHDA lesions of NAc was anticipated, animals exhibiting
slightly higher baseline activities (> 5000 cm in HA) were chosen for the lesion group
so that locomotor activity on ED 8 would be similar across all three groups. Similar to
the higher locomotor baseline of the lesion group, surgical shams had higher
locomotor activity. This was chosen to determine whether non-specific damage due to
administration of saline affected locomotor activity. Administering saline to NAc
(surgical shams) did not alter locomotor activity, but administering 6-OHDA to NAc
reduced locomotor activity. The decrease in locomotor activity following 6-OHDA
administration to NAc was consistent with the fact that DA in the NAc is believed to

have a role in locomotion via its circuitry to ventral pallidum / substantia innominata
(Austin and Kalivas, 1991).
However, the accuracy of the lesion is unknown as the lesions could not be
verified independently. It can be argued that the lesions caused DA depletion in the
NAc since the lesioned animals had significantly reduced locomotor activity, and DA
depletion in NAc has been reported to cause a decrease in locomotor activity. But, it
is possible that the 6-OHDA may have caused DA depletion in other structures. In
close proximity to the nucleus accumbens are the caudate and putamen, which are
also believed to be involved in locomotion (Makanjoula and Ashcroft, 1982).
Makanjoula and Ashcroft (1982) reported that 6-OHDA lesions of either NAc or
caudate putamen reduced spontaneous locomotor activity. They also reported the loss
of psychostimulant-induced locomotor activity following 6-OHDA administration to
the NAc and reduction in psychostimulant-induced stereotypic activity following 6OHDA administration to the caudate-putamen. The current results showed loss of the
MPD-induced increase in locomotor and stereotypic activity, so it is possible that the
lesion may have extended to the caudate-putamen or have lesioned the caudateputamen. But, the caudate-putamen is generally believed to have a role in stereotyped
activity than locomotion (Cho et al., 1999; Horner et al., 2010; Naylor and Olley,
1972). Thus, it seems more likely that the NAc was lesioned as compared to caudateputamen.
Upon acute injection of MPD, significant increases in locomotor activity were
seen in control and non-surgical sham groups for all three indices of activity
analyzed, namely HA, TD and NOS. The surgical shams did not have a significant

increase, but this may have been due to the small number of rats in this group (n = 4).
The ability of psychostimulants like MPD to elicit a locomotor response may be
attributed to their ability to affect the VTA-accumbens-pallidal circuitry.
Psychostimulants cause an increase in dopaminergic transmission from the VTA to
the NAc. This dopamine released from VTA neurons in the NAc inhibits the GABA
neurons in the NAc, which project to the terminal in ventral pallidum (VP) /
susbtantia innominata (SI) (Austin and Kalivas, 1991). It has been reported that
injecting picrotoxin, a GABA antagonist, in the ventral pallidum caused an increase
in locomotion (Mogenson and Nielson, 1983). Therefore, the inhibition of GABA
neurons in the NAc, by the DA released in NAc from VTA, results in increased
locomotion. Though exact mechanism(s) for this effect are unknown, it is believed
that the connections of ventral pallidum to the mediodorsal thalamic nucleus may be
involved. It is so conjectured since the mediodorsal thalamic nucleus projects to the
anterior cingulated cortex, which has been termed as the ‘likely forerunner of the
motor cortex’ due to its direct connections to the supplementary motor cortex and the
premotor cortex (Heimer et al., 1982).
The VTA-accumbens-pallidal circuitry described above may explain the
reduced acute response to MPD after 6OHDA lesion of the NAc. However,
electrolytic lesions of NAc did not prevent the acute response to MPD (Podet et al.,
submitted for publication). Therefore, the hypothesis was that destruction of
dopaminergic afferents to the NAc would not affect the acute response to MPD.
However, this was not found to be true. In fact, there were two distinct responses in
rats with 6-OHDA lesion of the NAc. Fig. 2C shows that while some animals

exhibited no increase in locomotor activity after the acute injection of MPD (acute
non-responders), others showed a significantly elevated locomotor activity (high
acute responders) following the acute administration of MPD. Each group (acute nonresponders and high acute responders) responded differently throughout the length of
the experiment. Therefore, the lesion group was further divided into two groups,
‘acute non-responders’ and ‘high acute responders’, based on acute response to MPD.
Both no response, and augmented response, to acute injection of
psychostimulant in 6-OHDA in NAc lesioned animals have been reported (Kelly et
al., 1975; Kelly and Iversen, 1976). While Kelly et al.(1975) reported that the NAc
(6-OHDA) lesioned rats did not show the characteristic locomotor response to an
acute injection of amphetamine, Kelly and Iversen(1976) reported augmented
locomotor activity response to amphetamine 3 days after the 6-OHDA NAc lesion.
However, as the time between the 6-OHDA lesion and the acute injection of
amphetamine differed between the two experiments (Kelly et al., 1975; Kelly and
Iversen, 1976), they rationalize that this difference in response to the acute
amphetamine injection in the NAc (6-OHDA) lesioned rats can be attributed to either
increased transmitter release from degenerating terminals or to super sensitization of
post-synaptic receptors, which may have caused the augmented locomotor response
to the release of transmitter. Such reasoning does not apply to the two distinct
responses seen in the current experiment since same amount of time was allowed
between the administration of 6-OHDA in NAc and the acute injection of MPD in
both the acute non-responders and the high acute responders.

It is, however, possible that the difference in acute response to
psychostimulant administration may be due to differences in the size or location of
the lesion, i.e., different subregions of NAc may have been lesioned, contributing to
the difference in acute response seen. The NAc is not a unitary structure (Pontieri et
al., 1995; Pierce and Kalivas, 1995); and psychostimulant drugs (DiChiara, 2002;
Pontieri et al., 1995) as well as stress (Deutch and Cameron, 1992) activate dopamine
transmission selectively in the NAc shell (Kalivas and Duffy, 1995). Acute
administration of psychostimulants has also been shown to preferentially increase
glucose utilization in the NAc shell compared to the core. Moreover, it has been
reported that microinfusions of DA D1 receptor agonists, or amphetamine, into the
NAc shell produce a greater increase in locomotor activity than injections into the
core (Swanson et al., 1997; Heidbreder and Feldon, 1998). Additionally, it has been
reported that it is the NAc shell that selectively innervates the ventromedial part
(VPm) of the subcommissural VP (Zahm and Heimer, 1993; Zahm and Heimer, 1990;
Heimer et al., 1991), which, in turn, projects to the thalamic mediodorsal nucleus
(Zahm, 2006). Thus, it is possible that the acute non-responders, not showing
augmentation of locomotor activity upon the acute injection of MPD, may have had
lesions that destroyed dopaminergic afferents of both the core and the shell, while the
lesion in animals of high acute responders, that had increased locomotor activity
following acute injection of MPD, may have had destruction of dopaminergic
afferents of the core only.
However, the converse has also been reported: that activation of locomotor
activity by amphetamine is blunted by 6-OHDA lesions of the core but not the medial

shell (Boye et al., 2001). Therefore, other reasons for the two responses seen may be
correct versus incorrect lesioning of the NAc, differences in locomotor baseline
between the two groups, and differences in DA depletion between the two lesion
groups. It can be argued that the diversity of response to the acute injection following
acute injection of MPD may suggest that while one group had accurate lesions of the
NAc, the other group may have had inaccurate lesions. However, since both the
lesion groups had significantly reduced locomotor activity after surgery (post-surgery
baseline), and reduction in locomotor activity has been linked with 6-OHDA lesions
of NAc, this suggests that accurate versus inaccurate lesioning of NAc may not be the
reason for the diverse responses to acute injection of MPD.
Differences in baseline locomotor activity are also known to contribute to
differences in acute response to psychostimulants (Hooks et al., 1991; Mathews et al.,
2010) and therefore, the post surgery baseline of the two lesion groups: high acute
responders and acute non-responders was compared (Fig. 2D). The post-surgery
baselines of the two lesion groups were not significantly different, so the two
responses to acute injection of MPD seen in the lesion group are not explained by
differences in baseline locomotor activity.
Another rationale for diversity of responses following acute injection of MPD
may be due to different amounts of DA depletion in NAc. Differences in DA
depletion may have caused differential reduction in the activation of distal excitatory
synaptic transmission (Nicola et al., 1996) and thus differences in the locomotor
response to acute injection of MPD. Further support for this rationale comes from
Bainton et al. (2000), who reported decreased response to acute cocaine in Drosophila

with pharmacologically reduced DA levels. Thus, it may be that the animals in the
high acute responders group had less DA depletion, whereas animals in acute nonresponders group may have had significant DA depletion in the NAc. As neither high
performance liquid chromatography (HPLC) nor tyrosine hydroxylase staining was
done, it is possible that differential depletion of DA may have resulted in two
responses in the NAc lesioned group to the acute injection of MPD. However, as the
same amount of 6-OHDA was administered in all animals in the lesion group, and the
different roles of NAc subcompartments are noted (DiChiara, 2002; DiChiara et al.,
2004), it is more likely that the high acute responders and acute non-responders
differed in the size or location of the lesion.
Following the 6th consecutive injection of MPD, the increase in locomotor
activity after the acute injection of MPD was maintained in the control group.
Similarly, in the non-surgical sham group, the increase after the 6th consecutive
injection of MPD was maintained. Generally, a sensitized response, i.e., significantly
elevated locomotor activity after repeated psychostimulant administration as
compared to the acute injection of the psychostimulant is obtained. However, this
sensitized response is not always reported (Martin-Iversen et al., 1988). A sensitized
response was seen in the surgical shams. But the increase seen in surgical sham group
was unexpectedly high. The reason for this is unclear and may be related to
alterations in the NAc due to saline during surgery. Alternatively, the induction of
sensitization observed in the surgical sham group might be exaggerated because they
had higher locomotor baseline. Hooks et al (1991) found that the magnitude of
sensitization was positively correlated to spontaneous activity. In the NAc 6-OHDA

lesioned animals, the acute non-responders showed a significantly greater increase in
locomotor activity as compared to that observed after the acute MPD injection (Fig.
3B). This may suggest that DA in the NAc core and shell may not be essential for
induction of behavioral sensitization. However, the acute injection of MPD failed to
elicit an increase in locomotor activity in the acute non-responders, so the above
interpretation may not be correct. The increase in activity following the 6th
consecutive injection of MPD in high acute responders was similar to the increase in
activity following the acute injection of MPD. Comparing the locomotor increases
following the 6th consecutive injection of MPD in the two lesion groups and the
control group, it can be noted that all three groups had similar increase in locomotor
activity by the 6th injection of MPD. This suggests that there is dissociation between
the neural circuitries underlying acute and chronic effects of MPD.
Finally, the rechallenge injection on ED 19 caused a significant increase in
locomotor activity compared to the acute injection of MPD i.e., sensitization was
expressed in the control and non-surgical sham group for the indices of HA and TD.
The surgical shams showed robust increases in HA, TD and NOS, but these did not
reach statistical significance. Given the increase seen in the surgical shams, the
difference may not have been statistically significant because of inadequate statistical
power, since there were only four rats in this group. In the NAc lesioned animals, the
acute non-responders had significantly higher locomotor activity i.e., sensitization
was expressed, while the high acute responders had similar levels of activity on both
the 1st and the rechallenge injection of MPD. Thus, the response of the high acute
responders may be interpreted in two ways: 1) expression of sensitization was

prevented in the high acute responders and 2) a sensitized response was elicited by
the 1st MPD injection itself. Since similar levels of locomotor activity were seen in
the control animals and the high acute responders and acute non-responders upon the
MPD rechallenge injection, it may be suggested that expression of sensitization was
not prevented by the lesion, and that a ‘sensitized-like’ response was observed upon
the 1st injection itself in high acute responders.
Previously, Beyer and Steketee (1999) reported that 6-OHDA lesions of the
medial PFC caused sensitized-like behavioral and neurochemical responses to an
acute injection of cocaine. However, they conjecture that this might be because the
DA depletion of mPFC (by cortical 6-OHDA lesions) removes the inhibition on
cortical glutamatergic neurons, which have connections to and influence NAc and
VTA (Christie et al., 1985; Sesack and Pickel, 1992). Thus, by removing the
inhibition, this allows for greater excitation of DA neurons in VTA and NAc.
Therefore, they rationalize that decreased DA in mPFC causes an increase in DA of
NAc, which correlates with the enhanced response to the acute injection of cocaine.
By contrast, we report that 6-OHDA lesions of NAc core, i.e., decrease of DA in the
NAc core is correlated with the sensitized response to the acute injection of MPD.
This might be due to pharmacological differences between the drugs or it might be
that DA depletion in mPFC may not correlate to increased levels of DA in NAc as
hypothesized by Beyer and Steketee (1999). Support for the latter explanation comes
from the findings of King et al. (1997), who reported that dopamine depletion in the
mPFC attenuated the amphetamine-induced increase in extracellular dopamine in the
NAc core. Thus, it is possible that the enhanced response to acute injection of cocaine

reported by Beyer and Steketee (1999) may be correlated with decreased levels of DA
in mPFC and NAc, since they measured DA levels in only mPFC and not NAc.
This finding, that the sensitized response is correlated with decreased DA in
NAc core, however, is not in concordance with other psychostimulants: for example,
Cadoni et al., 2000 reported that sensitization to amphetamine and cocaine (low
doses) was correlated with sensitization of DA transmission in the NAc core and not
to changes in the NAc shell. For higher doses of cocaine, Cadoni et al. (2000)
reported a reduction in DA transmission in the shell in addition to strengthened DA
transmission in the core. However, contradictory findings have also been reported:
Pierce and Kalivas (1995) reported that sensitization to amphetamine is correlated
with robust increase in DA transmission in the NAc shell. Thus, the changes,
associated with NAc structures and psychostimulant sensitization are conflicting even
for a single psychostimulant.
Moreover, if the difference in the responses of high acute responders and
acute non-responders are due to differences in size of the lesion, it would appear
paradoxical that the dopamine depletion in core and shell caused the response to acute
injection of MPD to be eliminated, while the dopamine depletion of the core alone
caused an increased response to the acute injection of MPD (Fig. 5). It is possible that
the DA in NAc shell is essential for the acute effect of MPD and that the sensitized
response is linked to reduced levels of DA in the NAc core in the presence of intact
DA transmission in the NAc shell. This may be a possibility since NAc core and shell
are known to exhibit differential resposiveness to drugs of abuse (Pontieri et al.,
1995) and conventional rewards (Bassareo and Di Chiara, 1999). Further support for

this paradoxical finding comes from Broening et al., 1997 who reported that
methamphetamine administration, which is neurotoxic to the dopaminergic
neurotransmitter system, destroyed dopaminergic innervation in the nucleus
accumbens core, whereas shell inntervation was resistant. They concluded that their
results support the hypothesis that there exists differential innervation to core and
shell by mesencephalic dopamine neurons. Thus, it is quite possible that the acute
injection of MPD specifically activates the innervation to the shell, and that the
innervation to the core is altered in sensitization to MPD.

FIGURE LEGEND:

Figure 5 shows the heterogeneity of NAc and suggests

that the acute effect of MPD is modulated by DA transmission in NAc shell, and the
‘sensitized-like’ augmented response may be due to alteration of DA transmission in
the NAc core.

Figure 5

The exact roles of NAc core and shell in the acute and chronic effects of MPD
reported here are speculations since the DA depletion and the accuracy of the lesions
are not known. The accuracy of the lesions could have been better determined with
the following methods instead of the cresyl violet staining used:
1)

High Pressure Liquid Chromatography: This is the most common way of

measuring the efficacy of 6-OHDA lesions and is used by most studies performing 6OHDA lesions (Beyer and Steketee, 1999; Bjijou et al., 2002; Carter and Pycock,
1980; Rassnick et al., 1993). In HPLC, the brain tissue from the area of interest is
homogenized and then assayed for DA and DOPAC concentrations using
electrochemical detection following separation by HPLC. This method would have
assessed the effectiveness of dopamine depletion by the lesions, but would not thrown
light on the location of the DA depletion. Since NAc is a heterogenous structure and
diverse responses were seen upon acute psychostimulant administration (high acute
responders and acute non-responders), performing HPLC would not have
distinguished whether the difference in response was due to differences in location of
DA depletion.
2)

Calbindin immunohistochemistry: This method would have been best to

distinguish ‘shell’ from ‘core’ in the histological verification of probe location
(DiChiara, 1999, 2002). The core of NAc is reported to stain darker with calbindin
than the shell (Meredith et al., 1996). However, since calbindin is a calcium binding
protein (Timurkaan and Taracki, 2004), calbindin immunohistochemistry would not
reveal anything about DA depletion, and thus might have been less useful about
highlighting the reason for the differences seen.

3)

Double labeling of tyrosine hydroxylase labeling and dopamine-beta-

hydroxylase (DBH) immunofluorescence: This double labeling would be most
useful since it has helped to assess DA depletion in the core and DA and
norepinephrine (NE) depletion in the shell, as well check the extent of DA
depletion. Tyrosine hydroxylase labels catecholaminergic neurons, whereas DBH is
more specific for noradrenergic and adrenergic neurons (Berod et al., 1982). As
described by Berod et al., 1982, the advantage of combining immunofluorescence
and immunoperoxidase techniques is that they yield very different staining and thus
making it easier to observe.
Future directions to verify these findings may include micro-dialysis studies to
correctly assess DA changes in core and shell associated with behavioral sensitization
to MPD. Also, it might be helpful to perform selective 6-OHDA lesions of only the
core or the shell to elucidate the role of each of the subcompartments of NAc in the
acute and chronic effects of MPD.
In conclusion, there were two patterns of response to MPD after 6OHDA
infusion. Low acute responders had no initial increase in activity, but developed
behavioral sensitization to repeated MPD. High acute responders had an enhanced
motor response to acute MPD, but had no further increase in motor activity. This
suggests that the subregions of NAc may have different roles in locomotor activity
induced by MPD. Further, even though some animals responded to the acute injection
of MPD and others did not; all the animals had similar levels of increased locomotor
activity by the 6th consecutive injection of MPD and the rechallenge injection. Thus,

the neural circuitry underlying the acute effect of MPD appears different from the
neural circuitry underlying behavioral sensitization to MPD.
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